Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu Ishizuya

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
International Journal of Clinical Oncology|June 8, 2024
Recent developments and future directions of first-line systemic therapy combined with immunotherapy for advanced or metastatic urothelial carcinoma: a historical perspective on treatment evolutionAtsunari Kawashima, Yu Ishizuya, Yoshiyuki Yamamoto, et al.
Hinyokika Kiyo. Acta Urologica Japonica|January 7, 2022
[A Case of Pelvic Lymph Node Recurrence Detected by PSMA PET/CT after Primary Proton Beam Radiotherapy for Prostate Cancer]Takuya Ito, Yuichiro Yamaguchi, Nobumasa Fujimoto, et al.
Japanese Journal of Clinical Oncology|October 14, 2016
Postoperative early ultrasensitive prostate-specific antigen identifies patients at risk for biochemical recurrence in margin positive prostate cancers: a single-center studyKoji Hatano, Takuya Okusa, Yu Ishizuya, et al.
International Cancer Conference Journal|June 1, 2019
Desperation surgery for a chemorefractory lung lesion in a patient with an extragonadal germ cell tumorYu Ishizuya, Takuya Okusa, Koji Hatano, et al.
Hinyokika Kiyo. Acta Urologica Japonica|December 6, 2016
[A Case of Renal Cell Carcinoma with Malignant Pleural Effusion Showing Marked Response to Axitinib]Yu Ishizuya, Takuya Okusa, Koji Hatano, et al.
Urology|December 9, 2021
Bladder Cancer in a Long-term Survivor of the Prune Belly SyndromeFuki Kondo, Fumi Matsumoto, Shinta Suenaga, et al.
IJU Case Reports|July 1, 2026
Acute Cardiac Tamponade Following Enfortumab Vedotin Initiation in Metastatic Urothelial Carcinoma: Successful Rescue by Pericardial FenestrationHiroto Akamatsu, Yu Ishizuya, Kentaro Takezawa, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|June 9, 2025
PARP Inhibitors in Genitourinary Cancer: A New Paradigm Beyond Prostate CancerYohei Okuda, Taigo Kato, Yu Ishizuya, et al.
Japanese Journal of Clinical Oncology|November 9, 2014
A single-center study on predicting outcomes of primary androgen deprivation therapy for prostate cancer using the Japan Cancer of the Prostate Risk Assessment (J-CAPRA) scoreYuichiro Yamaguchi, Yujiro Hayashi, Yu Ishizuya, et al.
International Cancer Conference Journal|July 8, 2025
Cancer genome profiling of prostate cancer identifies a patient with a novel <i>EFNA1-NTRK1</i> fusion geneTomohiro Kanaki, Koji Hatano, Shinichiro Tahara, et al.
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
International Journal of Clinical Oncology|June 8, 2024
Recent developments and future directions of first-line systemic therapy combined with immunotherapy for advanced or metastatic urothelial carcinoma: a historical perspective on treatment evolutionAtsunari Kawashima, Yu Ishizuya, Yoshiyuki Yamamoto, et al.
Hinyokika Kiyo. Acta Urologica Japonica|January 7, 2022
[A Case of Pelvic Lymph Node Recurrence Detected by PSMA PET/CT after Primary Proton Beam Radiotherapy for Prostate Cancer]Takuya Ito, Yuichiro Yamaguchi, Nobumasa Fujimoto, et al.
Japanese Journal of Clinical Oncology|October 14, 2016
Postoperative early ultrasensitive prostate-specific antigen identifies patients at risk for biochemical recurrence in margin positive prostate cancers: a single-center studyKoji Hatano, Takuya Okusa, Yu Ishizuya, et al.
International Cancer Conference Journal|June 1, 2019
Desperation surgery for a chemorefractory lung lesion in a patient with an extragonadal germ cell tumorYu Ishizuya, Takuya Okusa, Koji Hatano, et al.
Hinyokika Kiyo. Acta Urologica Japonica|December 6, 2016
[A Case of Renal Cell Carcinoma with Malignant Pleural Effusion Showing Marked Response to Axitinib]Yu Ishizuya, Takuya Okusa, Koji Hatano, et al.
Urology|December 9, 2021
Bladder Cancer in a Long-term Survivor of the Prune Belly SyndromeFuki Kondo, Fumi Matsumoto, Shinta Suenaga, et al.
IJU Case Reports|July 1, 2026
Acute Cardiac Tamponade Following Enfortumab Vedotin Initiation in Metastatic Urothelial Carcinoma: Successful Rescue by Pericardial FenestrationHiroto Akamatsu, Yu Ishizuya, Kentaro Takezawa, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|June 9, 2025
PARP Inhibitors in Genitourinary Cancer: A New Paradigm Beyond Prostate CancerYohei Okuda, Taigo Kato, Yu Ishizuya, et al.
Japanese Journal of Clinical Oncology|November 9, 2014
A single-center study on predicting outcomes of primary androgen deprivation therapy for prostate cancer using the Japan Cancer of the Prostate Risk Assessment (J-CAPRA) scoreYuichiro Yamaguchi, Yujiro Hayashi, Yu Ishizuya, et al.
International Cancer Conference Journal|July 8, 2025
Cancer genome profiling of prostate cancer identifies a patient with a novel <i>EFNA1-NTRK1</i> fusion geneTomohiro Kanaki, Koji Hatano, Shinichiro Tahara, et al.
Pageof 6